News By Tag
* Genetics Policy Institute
* More Tags...
News By Location
2014 World Stem Cell Summit Presented by Genetics Policy Institue, Mary Ann Liebert, Inc, and GEN
2014 World Stem Cell Summit to be Presented by Genetics Policy Institute, Mary Ann Liebert, Inc., and Genetic Engineering & Biotechnology News (GEN)
New Rochelle, NY—Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com/)
In a new collaborative effort in 2014, Mary Ann Liebert, Inc. will also organize a World Stem Cell Summit panel, comprised of leading editors from their peer-reviewed journals intersecting the field to predict the most innovative translational research that will impact regenerative medicine in the next five years.
Mary Ann Liebert, Inc. will also publish the 2014 World Stem Cell Report as a special supplement to the peer-reviewed journal Stem Cells and Development. Dr. Graham Parker, Editor-in-Chief of Stem Cells and Development, and Bernard Siegel, Executive Director of Genetics Policy Institute (GPI), will serve as Co-Editors-in-
"We are very pleased to expand our collaboration with Mary Ann Liebert, Inc., and GEN,” says Bernard Siegel, Founder and Co-chair of the Summit. “The commitment by those prestigious publishers to journalistic integrity and scientific knowledge and education matches our enthusiasm to advance the field of stem cells and regenerative medicine for the betterment of humanity. We look forward to working with Graham Parker and the skilled editorial team at Stem Cells and Development to publish our annual Report. We are especially excited to have the expertise of the Liebert editors engaged on the program at the World Stem Cell Summit.”
“The World Stem Cell Summit is unequivocally a paramount meeting that brings together the leaders in the field from academia, industry, and business, thereby ensuring the advancement of collaborative opportunities,”
GEN Editor-in-Chief John Sterling stated, "The World Stem Cell Summit is the critical global meeting, providing the best opportunity for the GEN community to participate in the world of regenerative medicine. Our platinum media sponsorship allows GEN readers and advertisers to have a front row seat to listen and learn from the top experts on the very dynamic and expertly conceptualized Summit platform."
The Summit program delivers on the "big picture," featuring over 200 prominent scientists, business leaders, regulators, policy-makers, advocates, economic development officers, experts in law and ethics, and visionary gurus who will discuss the latest scientific discoveries, business models, legal and regulatory solutions, and best practices. The Summit is expected to attract attendees from more than 40 nations.
About Mary Ann Liebert, Inc., publishers
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many areas of science and biomedical research. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website (http://www.liebertpub.com/
About Stem Cells and Development
Stem Cells and Development is an authoritative peer-reviewed journal dedicated to communication and objective analysis of developments in the biology, characteristics, and therapeutic utility of stem cells, especially those of the hematopoietic system. Complete tables of content and a free sample issue may be viewed on the Stem Cells and Development website (http://www.liebertpub.com/
About Genetic Engineering & Biotechnology News (GEN)
Genetic Engineering & Biotechnology News, published 21 times a year by Mary Ann Liebert, Inc., publishers, is the most widely read biotechnology news magazine worldwide. It includes articles on Drug Discovery, Bioprocessing, OMICS, Biobusiness, and Translational Medicine (http://www.genengnews.com).
About Genetics Policy Institute (GPI) and the World Stem Cell Summit
The Genetics Policy Institute (http://www.genpol.org)